{"product_id":"biolegend-300430","title":"Biolegend, 300430, PerCP\/Cyanine5.5 anti-human CD3 Antibody, 100tests","description":"\u003cp\u003eCD3ε is a 20 kD chain of the CD3\/T-cell receptor (TCR) complex which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T-cell receptor (α\/β or γ\/δ) heterodimer. It is found on all mature T cells, NKT cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.\u003cbr\u003e\n100tests\u003cbr\u003e\nVerified Reactivity: Human\u003cbr\u003e\nReported Reactivity: Chimpanzee\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PerCP\/Cyanine5.5 under optimal conditions.\u003cbr\u003e\nConcentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)\u003cbr\u003e\nStorage \u0026amp; Handling: The CD3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.* PerCP\/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections4,6,7 and formalin-fixed paraffin-embedded sections11, immunoprecipitation1, activation of T cells2,3,5, Western blotting9, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin \u0026lt; 0.1 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 300413, 300414, and 300432). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 300437, 300438, 300465, 300466, 300473, 300474) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin \u0026lt; 0.01 EU\/µg).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Salmeron A, et al. 1991. J. Immunol. 147:3047. (IP) Graves J, et al. 1991. J. Immunol. 146:2102. (Activ) Lafont V, et al. 2000. J. Biol. Chem. 275:19282. (Activ) Ryschich E, et al. 2003. Tissue Antigens 62:48. (IHC) Thompson AG, et al. 2004. J. Immunol. 173:1671. (Activ) Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immun. 5:430. (IHC) Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC) Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed Van Dongen JJM, et al. 1988. Blood 71:603. (WB) Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC) Pollard, K. et al. 1987. J. Histochem. Cytochem. 35:1329. (IHC) Luckashenak N, et al. 2013. J. Immunol. 190:27. PubMed Laurent AJ, et al. 2014. PLoS One. 9:103683. PubMed Li J, et al. 2015. Cancer Res. 75:508. PubMed Stoeckius M, et al. 2017. Nat. Methods. 14:865-868. (PG) Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed\u003cbr\u003e\nProduct Citations: Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed Chernyshev M, et al. 2023. Nat Commun. 14:2249. PubMed Lu T, et al. 2023. J Med Virol. 95:e28730. PubMed He T, et al. 2022. Liver Int. 42:1287. PubMed Höfle J, et al. 2022. EMBO Rep. 23:e54133. PubMed Ding L, et al. 2023. J Clin Invest. 133: . PubMed Sun W, et al. 2023. Nature. 614:309. PubMed Guo Q, et al. 2023. Front Public Health. 10:1067342. PubMed Peng W, et al. 2023. Cells. 12: . PubMed Larivière L, et al. 2023. Int J Pharm X. 5:100157. PubMed Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed Zhang S, et al. 2023. J Clin Med. 12: . PubMed Poonia B, Pauza C 2014. PLoS One. 9:88884. PubMed Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed Xu L, et al. 2018. Mol Oncol. 12:269. PubMed Shoda H, et al. 2017. Arthritis Research \u0026amp; Therapy . 10.1186\/s13075-017-1308-y. PubMed Li H, et al. 2022. Front Immunol. 13:988004. PubMed Nakano M, et al. 2021. Front Immunol. 12:713225. PubMed Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed Yeung Y, et al. 2016. Nat Commun. 7:13376. PubMed Armour K, et al. 2014. PLoS One. 9:109463. PubMed Chen M, et al. 2021. Cancers (Basel). 13:. PubMed Porsche CE, et al. 2021. JCI Insight. 6:. PubMed Rajakumar SA, et al. 2021. Cell Rep Med. 2:100470. PubMed Li T, et al. 2022. Int J Infect Dis. 122:874. PubMed Mbiribindi B, et al. 2020. Sci Rep. 10:19973. PubMed Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed Etxeberria I, et al. 2020. Cancer Cell. 36(6):613-629. PubMed Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed Zhang M, et al. 2020. J Cell Mol Med. . PubMed Jilkova Z, et al. 2017. Mediators Inflamm. 10.1155\/2017\/3214917. PubMed van Heerden D, et al. 2021. Int J Mol Sci. 22:. PubMed Turner AW, et al. 2020. ACS Infect Dis. 6:1719. PubMed Shen M, et al. 2018. Int J Oncol. 53:317. PubMed Herrera FG, et al. 2019. Int J Radiat Oncol Biol Phys. 103:320. PubMed Ye C, et al. 2017. J Virol. 91:e01389-23. PubMed Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed Aydin AM, et al. 2021. Int Immunopharmacol. 94:107481. PubMed Xu S, et al. 2021. Immunity. . PubMed Sumitomo S, et al. 2017. J Autoimmun.. 10.1016\/j.jaut.2017.11.001. PubMed Vendrame E, et al. 2020. AIDS. 34:801. PubMed Song R, et al. 2022. Front Immunol. 13:1028246. PubMed Pritchett J, et al. 2016. J Infect Dis. 214(12):1911-1915. PubMed Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed Nakachi S, et al. 2017. Arthritis Research \u0026amp; Therapy . 10.1186\/s13075-017-1309-x. PubMed Sicklinger F, et al. 2021. J Clin Invest. 131:. PubMed Khuzwayo S, et al. 2021. Front Immunol. 12:631410. PubMed Shehata L, et al. 2019. Cell Rep. 28:3300. PubMed Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed Gross C, et al. 2016. Proc Natl Acad Sci U S A. 113: 2973 - 2982. PubMed Körner C et al. 2017. Cell host \u0026amp; microbe. 22(1):111-119 . PubMed Rappazzo CG, et al. 2022. Immunity. 55:1710. PubMed Fels JM, et al. 2021. Cell. 184(13):3486-3501.e21. PubMed Dulberger CL et al. 2017. Immunity. 46(6):1018-1029 . PubMed Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed Teirlinck A, et al. 2015. Infect Immun . 83: 3732-3739. PubMed Shehata L, et al. 2019. Nat Commun. 10:1126. PubMed Portillo AL, et al. 2021. iScience. 24(6):102619. PubMed Poznanski SM, et al. 2021. Cell Metabolism. 33(6):1205-1220.e5. PubMed Ribot J, et al. 2014. J Immunol. 192:2237. PubMed Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed Brunk F, et al. 2021. Eur J Immunol. 51:2651. PubMed\u003cbr\u003e\nRRID: AB_893301 (BioLegend Cat. No. 300429) AB_893299 (BioLegend Cat. No. 300430)\u003cbr\u003e\nStructure: Ig superfamily, with the subunits of CD3γ, CD3δ, CD3ζ (CD247) and TCR (α\/β or γ\/δ) forms CD3\/TCR complex, 20 kD\u003cbr\u003e\nDistribution: Mature T and NK T cells, thymocyte differentiation\u003cbr\u003e\nFunction: Antigen recognition, signal transduction, T cell activation\u003cbr\u003e\nLigand\/Receptor: Peptide antigen bound to MHC\u003cbr\u003e\nCell Type: NKT cells, T cells, Thymocytes, Tregs\u003cbr\u003e\nBiology Area: Immunology, Innate Immunity\u003cbr\u003e\nMolecular Family: CD Molecules, TCRs\u003cbr\u003e\nAntigen References: 1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego. 2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329. 3. Lanier L, et al. 1986. J. Immunol. 137:2501-2507.\u003cbr\u003e\nGene ID: 916\u003cbr\u003e\nUniProt: View information about CD3 on UniProt.org\u003cbr\u003e\nClone: UCHT1\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nWorkshop: III 471\u003cbr\u003e\nOther Names: T3, CD3ε\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003cbr\u003e\nQ: How stable is PerCP\/Cyanine5.5 tandem as compared to PerCP alone?\u003cbr\u003e\nA: PerCP\/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46864075096233,"sku":"300430","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-300430","provider":"Iright","version":"1.0","type":"link"}